YERVOY contains the active substance ipilimumab, a protein which helps your immune system to attack and destroy cancer cells by your immune cells.
YERVOY is used to treat advanced melanoma (a type of skin cancer) in adults.
YERVOY contains the active substance ipilimumab, a protein which helps your immune system to attack and destroy cancer cells by your immune cells.
YERVOY is used to treat advanced melanoma (a type of skin cancer) in adults.
YERVOY should not be administered to you:
Tell your doctor or healthcare provider before being given the injection: YERVOY may cause:
Tell your doctor immediately if you have any of these signs or symptoms or they get worse. Do not try to treat your symptoms with other medicines. Your doctor may give you other medicines in order to prevent more severe complications and reduce your symptoms, withhold the next dose of YERVOY, or stop your treatment with YERVOY altogether.
Please note that these signs and symptoms are sometimes delayed and may develop weeks or months after your last dose. Before treatment, your doctor will check your general health. You will also have blood tests during treatment.
Check with your doctor or healthcare professional before you are given YERVOY:
YERVOY should not be used in children below 18 years of age.
Always tell your healthcare provider if you are taking any other medicine. (This includes all complementary or traditional medicines.) Before you are given YERVOY, tell your doctor:
Do not take any other medicines during your treatment without talking to your doctor first. Based on early data, the combination of YERVOY and vemurafenib is not recommended due to increased toxicity to the liver.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, please consult your doctor, pharmacist or other healthcare provider for advice before receiving YERVOY. Do not use YERVOY if you are pregnant. The active substance, ipilimumab, could harm an unborn baby.
Do not drive, cycle or use machines after you have been given YERVOY unless you are sure you are feeling well. Feeling tired or weak is a very common side effect of YERVOY. This can affect your ability to drive, cycle or to use machines.
YERVOY contains sodium Tell your doctor if you are on a low - sodium (low - salt) diet before you are given YERVOY. It contains 2,3 mg sodium per ml of concentrate.
Do not share medicines prescribed for you with any other person.
You will not be expected to give yourself YERVOY. It will be given to you by a person who is qualified to do so. YERVOY will be given to you in a hospital or clinic under the supervision of an experienced doctor. It will be given to you as an infusion (a drip) into a vein (intravenously) over a period of 90 minutes.
The recommended dose is 3 mg of ipilimumab per kilogram of your body weight. The amount of YERVOY you will be given will be calculated based on your body weight. Depending on your dose, some or all of the content of the YERVOY vial may be diluted with sodium chloride 9 mg/ml (0,9 %) solution for injection or 50 mg/ml (5 %) glucose solution for injection before use. More than one vial may be necessary to obtain the required dose. You will be treated with YERVOY once every 3 weeks, for a total of 4 doses. You may notice the appearance of new lesions or growth of existing lesions on your skin, which can be expected when you are being treated with YERVOY. Your doctor will continue giving you YERVOY for a total of 4 doses, depending on your tolerance to the treatment.
Since a healthcare professional will administer YERVOY, he/she will control the dosage. However, in the event of overdosage your doctor will manage the overdosage.
It is very important for you to keep all your appointments to receive YERVOY. If you miss an appointment, ask your doctor when to schedule your next dose.
Stopping your treatment may stop the effect of YERVOY. Do not stop treatment with YERVOY unless you have discussed this with your doctor. If you have any further questions about your treatment or the use of YERVOY, ask your doctor.
YERVOY can have side effects. Not all side effects reported for YERVOY are included in this leaflet. Should your general health worsen or if you experience any untoward effects while receiving YERVOY, please consult your doctor, pharmacist or other healthcare professional for advice. Be aware of important symptoms of inflammation. YERVOY acts on your immune system and may cause inflammation in parts of your body. Inflammation may cause serious damage to your body and some inflammatory conditions may be life-threatening. YERVOY can also cause hypersensitivity (allergic) reactions. Tell your doctor immediately if you get any of the following side effects.
Do not try to treat your symptoms with other medicines. The following side effects have been reported in patients receiving YERVOY:
YERVOY may cause changes in the results of tests carried out by your doctor. These include:
If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
If you get side effects, talk to your doctor, pharmacist or nurse. You can also report side effects to SAHPRA via the Med Safety APP (Medsafety X SAHPRA) and eReporting platform (who-umc.org) found on SAHPRA website. By reporting side effects, you can help provide more information on the safety of YERVOY.
Store all medicines out of reach of children.
Store in a refrigerator (2 °C – 8 °C).
Store in the original package in order to protect from light. Do not freeze.
For single use only. Discard any unused portion. Once opened, the product should be infused or diluted and infused immediately. The chemical and physical in-use stability of the undiluted or diluted concentrate (between 1 mg/ml and 4 mg/ml) has been demonstrated for 24 hours at 25 °C and 2 °C to 8 °C. If not used immediately, the infusion solution (undiluted or diluted) may be stored for up to 24 hours either under refrigeration (2 °C to 8 °C) or at room temperature (25 °C).
Do not use YERVOY after the expiry date which is stated on the carton and the vial label after EXP. The expiry date refers to the last day of that month.
The Yervoy 5 mg Solution professional information leaflet below is the property of Equity Pharmaceutical and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
The patient information text is available above. Load the original PDF only when you need it.